Cite
METS-IR, a Novel Simple Insulin Resistance Index, is Associated with NAFLD in Patients with Type 2 Diabetes Mellitus
MLA
Ma,Xuan, et al. METS-IR, a Novel Simple Insulin Resistance Index, Is Associated with NAFLD in Patients with Type 2 Diabetes Mellitus. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1469376845&authtype=sso&custid=ns315887.
APA
Ma,Xuan, Ji,Baolan, Du,Wenhua, Shi,Shuwei, Zhao,Hongyan, Sheng,Jie, Jiang,Xinghe, Ban,Bo, & Gao,Guanqi. (2024). METS-IR, a Novel Simple Insulin Resistance Index, is Associated with NAFLD in Patients with Type 2 Diabetes Mellitus.
Chicago
Ma,Xuan, Ji,Baolan, Du,Wenhua, Shi,Shuwei, Zhao,Hongyan, Sheng,Jie, Jiang,Xinghe, Ban,Bo, and Gao,Guanqi. 2024. “METS-IR, a Novel Simple Insulin Resistance Index, Is Associated with NAFLD in Patients with Type 2 Diabetes Mellitus.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1469376845&authtype=sso&custid=ns315887.